UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000032900 |
|---|---|
| Receipt number | R000037213 |
| Scientific Title | Functional outcome after carbon ion radiotherapy for pelvic bone sarcoma |
| Date of disclosure of the study information | 2018/06/08 |
| Last modified on | 2021/06/08 16:42:17 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Functional outcome after carbon ion radiotherapy for pelvic bone sarcoma
Acronym
Functional outcome after carbon ion radiotherapy for pelvic bone sarcoma
Scientific Title
Functional outcome after carbon ion radiotherapy for pelvic bone sarcoma
Scientific Title:Acronym
Functional outcome after carbon ion radiotherapy for pelvic bone sarcoma
Region
| Japan |
Condition
Condition
pelvic bone sarcoma
Classification by specialty
| Orthopedics | Radiology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
Retrospective analysis of limb function and adverse events in pelvic bone sarcoma patients after carbon ion radiotherapy
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Others
Trial characteristics_2
Others
Developmental phase
Not applicable
Assessment
Primary outcomes
limb function
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 10 | years-old | < |
Age-upper limit
| 99 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
pelvic bone sarcoma patients treated with carbon ion radiotherapy
Key exclusion criteria
sacral bone sarcoma
Target sample size
50
Research contact person
Name of lead principal investigator
| 1st name | Reiko |
| Middle name | |
| Last name | Imai |
Organization
National Institute of Quantum and Radiological Science and Technology
Division name
Hospital of the National Institute of Radiological Sciences
Zip code
263-0024
Address
4-9-1 Anagawa, Inage, Chiba, Japan
TEL
043-382-3703
imai.reiko@qst.go.jp
Public contact
Name of contact person
| 1st name | Reiko |
| Middle name | |
| Last name | Imai |
Organization
National Institute of Quantum and Radiological Science and Technology
Division name
Hospital of the National Institute of Radiological Sciences
Zip code
263-0024
Address
4-9-1 Anagawa, Inage, Chiba, Japan
TEL
043-382-3703
Homepage URL
helsinki@qst.go.jp
Sponsor or person
Institute
National Institute of Quantum and Radiological Science and Technology
Institute
Department
Personal name
Funding Source
Organization
National Institute of Quantum and Radiological Science and Technology
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Japan
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
National Institutes for Quantum and Radiological Science and Technology Certified Review Board
Address
4-9-1 Anagawa, Inage, Chiba,Japan
Tel
043-382-3703
helsinki@qst.go.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2018 | Year | 06 | Month | 08 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2018 | Year | 04 | Month | 25 | Day |
Date of IRB
| 2018 | Year | 05 | Month | 23 | Day |
Anticipated trial start date
| 2018 | Year | 05 | Month | 23 | Day |
Last follow-up date
| 2020 | Year | 03 | Month | 01 | Day |
Date of closure to data entry
| 2020 | Year | 03 | Month | 01 | Day |
Date trial data considered complete
| 2020 | Year | 03 | Month | 01 | Day |
Date analysis concluded
| 2020 | Year | 06 | Month | 01 | Day |
Other
Other related information
retrospective analysis and questionnaire survey
Management information
Registered date
| 2018 | Year | 06 | Month | 07 | Day |
Last modified on
| 2021 | Year | 06 | Month | 08 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037213
